Evidence map›Paper›PMID 25736458›Full record

ArticleMucosal immunology2015

Response to "In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: implications of the innate immune response".

E López-Collazo, T Jurado, J de Dios Caballero, M Pérez-Vázquez, A Vindel, E Hernández-Jiménez, J Tamames, C Cubillos-Zapata, M Manrique, R Tobes and 4 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

E López-Collazo1] Tumor Immunology Laboratory, IdiPAZ, Madrid, Spain [2] Innate Immunity Group, IdiPAZ, La Paz Hospital, Madrid, Spain.
T JuradoTumor Immunology Laboratory, IdiPAZ, Madrid, Spain.
J de Dios CaballeroDepartment of Microbiology, University Hospital Ramón y Cajal and IRYCIS, Madrid, Spain.
M Pérez-VázquezNational Biotechnology Center, CSIC, Madrid, Spain.
A VindelNational Biotechnology Center, CSIC, Madrid, Spain.
E Hernández-JiménezTumor Immunology Laboratory, IdiPAZ, Madrid, Spain.
J TamamesNational Microbiology Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
C Cubillos-ZapataTumor Immunology Laboratory, IdiPAZ, Madrid, Spain.
M ManriqueOh no sequences! Research group, Era7 Bioinformatics, Granada, Spain.
R TobesOh no sequences! Research group, Era7 Bioinformatics, Granada, Spain.
L MáizCystic Fibrosis Unit, Ramón y Cajal University Hospital, Madrid, Spain.
R Cantón1] National Microbiology Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain [2] Cystic Fibrosis Unit, Ramón y Cajal University Hospital, Madrid, Spain [3] Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
F Baquero1] National Microbiology Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain [2] CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
R del Campo1] National Microbiology Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain [2] CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, InnateBronchiCystic FibrosisHumansMaleMethicillin-Resistant Staphylococcus aureusStaphylococcal Infections

Identifiers

PMID25736458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.